J&J axes pair of CAR-T therapies for lymphoma, citing evolving market

May 1, 2026 07:07 AM EDT R&DCell/Gene Tx J&J ax­es pair of CAR-T ther­a­pies for lym­phoma, cit­ing evolv­ing mar­ket Ayisha Sharma News Reporter John­son & John­son is scrap­ping two CAR-T cell pro­grams for B cell lym­phoma amid a wave of ap­provals in re­cent years for cell ther­a­pies and … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER